Testicular growth and spermatogenesis: new goals for pubertal hormone replacement in boys with hypogonadotropic hypogonadism? -a multicentre prospective study of hCG/rFSH treatment outcomes during adolescence-

Clinical Endocrinology

Volumn 86, Issue 1, 2017, Pages 75-87

  Rohayem, Julia ^a   Hauffa, Berthold P ^b   Zacharin, Margaret ^c   Kliesch, Sabine ^a   Zitzmann, Michael ^a   Wüsthof, Achim ^d   Tittel, Bettina ^d   Morlot, Michel ^d   Vorhoff, Walburga ^d   Müller Rossberg, Elke ^d   Wagner, Verena ^d   Konrad, Katja ^d   Salzgeber, Kirsten ^d   Fricke Otto, Susanne ^d   Wölfle, Joachim ^d   Willig, Peter ^d   Karges, Beate ^d   Lankes, Erwin ^d   Droste, Michael ^d   Richter Unruh, Annette ^d   Liesenkötter, Klaus Peter ^d   Hübner, Angela ^d   Zichner, Stefanie ^d   Welzel, Maik ^d   Dunstheimer, Desiree ^d   Potelajew, Ulrike ^d   Heger, Sabine ^d   Hammer, Elke ^d   Oevering, Rudolf ^d   Schmidt, Silke ^d   Nieschlag, Eberhard ^d   more..

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

^c ROYAL CHILDREN'S HOSPITAL   (Australia)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; FOLLITROPIN; INHIBIN B; MUELLERIAN INHIBITING FACTOR; RECOMBINANT FOLLITROPIN; TESTOSTERONE; TESTOSTERONE ENANTATE; BIOLOGICAL MARKER; INHIBIN;

ADOLESCENT; ADULT; ANDROGEN THERAPY; ARTICLE; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE INCREASE; HORMONE BLOOD LEVEL; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; MALE; MULTICENTER STUDY; ORGAN GROWTH; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; SPERMATOGENESIS; SPERMATOZOON DENSITY; TESTIS; TESTOSTERONE BLOOD LEVEL; YOUNG ADULT; BLOOD; CLINICAL TRIAL; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; HORMONE SUBSTITUTION; HYPOGONADISM; PUBERTY;

ADOLESCENT; ANTI-MULLERIAN HORMONE; BIOMARKERS; CHORIONIC GONADOTROPIN; FOLLICLE STIMULATING HORMONE; HORMONE REPLACEMENT THERAPY; HUMANS; HYPOGONADISM; INHIBINS; MALE; PROSPECTIVE STUDIES; PUBERTY; QUALITY OF LIFE; SPERMATOGENESIS; TESTIS; TESTOSTERONE; YOUNG ADULT;

EID: 84986317235     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.13164     Document Type: Article

References (40)

1. Kliesch, S., Behre, H.M. & Nieschlag, E. (1994) High efficacy of gonadotropin or pulsatile gonadotropin-releasing hormone treatment in hypogonadotropic hypogonadal men. European Journal of Endocrinology, 131, 347–354.
2. Burgués, S. & Calderón, M.D. (1997) Subcutaneous self-administration of highly purified follicle stimulating hormone and human chorionic gonadotropin for the treatment of male hypogonadotropic hypogonadism. Human Reproduction, 12, 980–986.
3. Büchter, D., Behre, H.M., Kliesch, S. et al. (1998) Pulsatile GnRH or human chorionic gonadotropin/human menopausal gonadotropin as effective treatment for men with hypogonadotropic hypogonadism: a review of 42 cases. European Journal of Endocrinology, 139, 298–303.
4. European Metrodin HP Study Group EMHSG (1998) Efficacy and safety of highly purified urinary follicle-stimulating hormone with human chorionic gonadotropin for treating men with isolated hypogonadotropic hypogonadism. European Metrodin HP Study Group. Fertility and Sterility, 70, 256–262.
5. Bouloux, P., Warne, D.W. & Loumaye, E. (2002) Efficacy and safety of recombinant human follicle-stimulating hormone in men with isolated hypogonadotropic hypogonadism. Fertility and Sterility, 77, 270–273.
6. Liu, L., Banks, S.M., Barnes, K.M. et al. (1988) Two-year comparison of testicular responses to pulsatile gonadotropin-releasing hormone and exogenous gonadotropins from the inception of therapy in men with isolated hypogonadotropic hypogonadism. Journal of Clinical Endocrinology and Metabolism, 67, 1140–1145.
7. Schopohl, J. (1993) Pulsatile gonadotropin releasing hormone versus gonadotropin treatment of hypothalamic hypogonadism in males. Human Reproduction, 8, 175–179.
8. Barrio, R., De Luis, D., Alonso, M. et al. (1999) Induction of puberty with human chorionic gonadotropin and follicle- stimulating hormone in adolescent males with hypogonadotropic hypogonadism. Fertility and Sterility, 71, 244–248.
9. Raivio, T., Wikström, A.M. & Dunkel, L. (2007) Treatment of gonadotropin-deficient boys with recombinant human FSH: long-term observation and outcome. European Journal of Endocrinology, 156, 105–111.
10. Sinisi, A.A., Esposito, D., Maione, L. et al. (2008) Seminal anti-Mullerian hormone level is a marker of spermatogenic response during long-term gonadotropin therapy in male hypogonadotropic hypogonadism. Human Reproduction, 23, 1029–1034.
11. Zacharin, M., Sabin, M.A., Nair, V.V. et al. (2012) Addition of recombinant follicle-stimulating hormone to human chorionic gonadotropin treatment in adolescents and young adults with hypogonadotropic hypogonadism promotes normal testicular growth and may promote early spermatogenesis. Fertility and Sterility, 98, 836–842.
12. Shiraishi, K., Oka, S. & Matsuyama, H. (2014) Assessment of quality of life during gonadotropin treatment for male hypogonadotropic hypogonadism. Clinical Endocrinology, 81, 259–265.
13. Cooper, T.G., Noonan, E., von Eckardstein, S. et al. (2010) World Health Organization reference values for human semen characteristics. Human Reproduction Update, 16, 231–245.
14. Wurst, E., Herle, M., Fuiko, R. et al. (2002) The quality of life of chronically ill and psychiatrically disturbed children. Initial experiences with an inventory for assessing quality of life in children and adolescents. Zeitschrift fur Kinder- und Jugendpsychiatrie und Psychotherapie, 30, 21–28.
15. Steck, B., Grether, A., Amsler, F. et al. (2007) Disease variables and depression affecting the process of coping in families with a somatically ill parent. Psychopathology, 40, 394–404.
16. Cracco, E., Van Durme, K. & Braet, C. (2015) Validation of the FEEL-KJ: an Instrument to Measure Emotion Regulation Strategies in Children and Adolescents. PLoS ONE, 10, e0137080. doi: 10.1371/journal.pone.0137080.
17. Behre, H.M., Nashan, D. & Nieschlag, E. (1989) Objective measurement of testicular volume by ultrasonography: evaluation of the technique and comparison with orchidometer estimates. International Journal of Andrology, 12, 395–403.
18. Bistritzer, T., Lunenfeld, B., Passwell, J.H. et al. (1989) Hormonal therapy and pubertal development in boys with selective hypogonadotropic hypogonadism. Fertility and Sterility, 52, 302–306.
19. Gong, C., Liu, Y., Qin, M. et al. (2015) Pulsatile GnRH is superior to hCG in therapeutic efficacy in adolescent boys with hypogonadotropic hypogonadodism. Journal of Clinical Endocrinology and Metabolism, 100, 2793–2799. doi:10.1210/jc.2015-1343.
20. Siris, E.S., Nisula, B.C., Catt, K.J. et al. (1978) New evidence for intrinsic follicle-stimulating hormone-like activity in human chorionic gonadotropin and luteinizing hormone. Endocrinology, 102, 1356–1361.
21. Matsumoto, A.M., Karpas, A.E. & Bremner, W.J. (1986) Chronic human chorionic gonadotropin administration in normal men: evidence that follicle-stimulating hormone is necessary for the maintenance of quantitatively normal spermatogenesis in man. Journal of Clinical Endocrinology and Metabolism, 62, 1184–1192.
22. Tapanainen, J.S., Aittomaki, K., Min, J. et al. (1997) Men homozygous for an inactivating mutation of the follicle-stimulating hormone (FSH) receptor gene present variable suppression of spermatogenesis and fertility. Nature Genetics, 15, 205–206.
23. Maddock, W.O. & Nelson, W.O. (1952) The effects of chorionic gonadotropin in adult men: increased estrogen and 17-ketosteroid excretion, gynecomastia, leydig cell stimulation and seminiferous tubule damage. Journal of Clinical Endocrinology and Metabolism, 12, 985–1014.
24. Lytton, B. & Kase, N. (1966) Effects of human menopausal gonadotropin on a eunuchoidal male. New England Journal of Medicine, 274, 1061–1064.
25. Kliesch, S., Behre, H.M. & Nieschlag, E. (1995) Recombinant human follicle-stimulating hormone and human chorionic gonadotropin for induction of spermatogenesis in a hypogonadotropic male. Fertility and Sterility, 63, 1326–1328.
26. Warne, D.W., Decosterd, G., Okada, H. et al. (2009) A combined analysis of data to identify predictive factors for spermatogenesis in men with hypogonadotropic hypogonadism treated with recombinant human follicle-stimulating hormone and human chorionic gonadotropin. Fertility and Sterility, 92, 594–604.
27. ®): long-term treatment in azoospermic men with hypogonadotropic hypogonadism. Fertility and Sterility, 92, 979–990.
28. Dwyer, A.A., Quinton, R., Morin, D. et al. (2014) Identifying the unmet health needs of patients with congenital hypogonadotropic hypogonadism using a web-based needs assessment: implications for online interventions and peer-to-peer support. Orphanet Journal of Rare Diseases, 9, 83. doi:10.1186/1750-1172-9-83.
29. Miyagawa, Y., Tsujimura, A., Matsumiya, K. et al. (2005) Outcome of gonadotropin therapy for male hypogonadotropic hypogonadism at university affiliated male infertility centers: a 30-year retrospective study. Journal of Urology, 173, 2072–2075.
30. Liu, P.Y., Gebski, V.J., Turner, L. et al. (2002) Predicting pregnancy and spermatogenesis by survival analysis during gonadotropin treatment of gonadotropin-deficient infertile men. Human Reproduction, 17, 625–633.
31. Rohayem, J., Sinthofen, N., Nieschlag, E. et al. (2016) Causes of hypogonadotropic hypogonadism predict response to gonadotropin substitution in adults. Andrology, 4, 87–94.
32. Rastrelli, G., Corona, G., Mannucci, E. et al. (2014) Factors affecting spermatogenesis upon gonadotropin-replacement therapy: a meta-analytic study. Andrology, 2, 794–808.
33. Liu, P.Y., Baker, H.W.G., Jayadev, V. et al. (2009) Induction of spermatogenesis and fertility during gonadotropin treatment of Gonadotropin-Deficient infertile men: predictors of fertility outcome. Journal of Clinical Endocrinology and Metabolism, 94, 801–808.
34. Pitteloud, N., Hayes, F.J., Boepple, P.A. et al. (2002) The role of prior pubertal development, biochemical markers of testicular maturation, and genetics in elucidating the phenotypic heterogeneity of idiopathic hypogonadotropic hypogonadism. Journal of Clinical Endocrinology and Metabolism, 87, 152–160.
35. Kirk, J.M.W., Savage, M.O., Grant, D.B. et al. (1994) Gonadal function and response to human chorionic and menopausal gonadotropin therapy in male patients with idiopathic hypogonadotropic hypogonadism. Clinical Endocrinology, 41, 57–63.
36. Pitteloud, N., Hayes, F.J., Dwyer, A. et al. (2002) Predictors of outcome of long-term GnRH therapy in men with idiopathic hypogonadotropic hypogonadism. Journal of Clinical Endocrinology and Metabolism, 87, 4128–4136.
37. Mitchell, A.L., Dwyer, A., Pitteloud, N. et al. (2011) Genetic basis and variable phenotypic expression of Kallmann syndrome: towards a unifying theory. Trends in Endocrinology and Metabolism, 22, 249–258.
38. Waldstreicher, J., Seminara, S.B., Jameson, J.L. et al. (1996) The genetic and clinical heterogeneity of gonadotropin-releasing hormone deficiency in the human. Journal of Clinical Endocrinology and Metabolism, 81, 4388–4395.
39. Bougneres, P., Francois, M., Pantalone, L. et al. (2008) Effects of an early postnatal treatment of hypogonadotropic hypogonadism with a continuous subcutaneous infusion of recombinant follicle-stimulating hormone and luteinizing hormone. Journal of Clinical Endocrinology and Metabolism, 93, 2202–2205.
40. Dwyer, A.A., Sykitios, G.P., Hayes, F.J. et al. (2013) Trial of recombinant follicle-stimulating hormone pretreatment for GnRH-induced fertility in patients with congenital hypogonadotropic hypogonadism. Journal of Clinical Endocrinology and Metabolism, 98, E1790–E1795.